Clinical trial

Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus

NCT03462017

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention SAR247799 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Sildenafil Normalized identity: sildenafilView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Acetylcholine Normalized identity: acetylcholineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-03-07

PhasePHASE1

Conditions

Microvascular Coronary Artery Diseaseunresolved

Interventions

SAR247799DRUG

PlaceboDRUG

SildenafilDRUG · verified · RxNorm: sildenafil

AcetylcholineDRUG · verified · RxNorm: acetylcholine

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

MainzGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03462017 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.